Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Optiver Holding’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,900	Closed	-$77.2K	–	706
2023 Q4	$77.2K	Sell	1,900 -6,400	-77%	-$236K	﹤0.01%	413
2023 Q3	$287K	Sell	8,300 -67,200	-89%	-$2.62M	﹤0.01%	424
2023 Q2	$3.07M	Sell	75,500 -16,700	-18%	-$681K	﹤0.01%	334
2023 Q1	$3.56M	Buy	92,200 +9,800	+12%	+$403K	﹤0.01%	336
2022 Q4	$3.66M	Sell	82,400 -127,900	-61%	-$5.38M	﹤0.01%	284
2022 Q3	$8.97M	Buy	210,300 +46,600	+28%	+$2.39M	0.01%	188
2022 Q2	$9.13M	Sell	163,700 -39,600	-19%	-$2.35M	0.01%	166
2022 Q1	$12.6M	Sell	203,300 -40,900	-17%	-$2.5M	0.01%	135
2021 Q4	$13M	Buy	244,200 +77,300	+46%	+$4.03M	0.01%	155
2021 Q3	$8.78M	Sell	166,900 -8,600	-5%	-$511K	0.01%	143
2021 Q2	$12.1M	Buy	+175,500	New	+$13.4M	0.02%	109
2021 Q1	–	Hold	0	–	–	–	69

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Optiver Holding's LKFT Position: Q1 2026 in Review

Optiver Holding opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 26,535 shares worth $796K. The stake represents ﹤0.01% of the portfolio and ranks #582 among its holdings. This is a return to the name: Optiver Holding previously reported a position in LKFT as recently as Q2 2025.

Optiver Holding first reported a position in LKFT in Q2 2021 and has held it in 15 quarters since. The position peaked at $17.4M in Q2 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Optiver Holding held 26,535 shares of Lakefront Biotherapeutics American Depositary Shares worth $796K as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Optiver Holding position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #582 holding.
Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and has held it in 15 quarters since.
Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.